Aflac Incorporated's SEC filings document a supplemental health and life insurer with reportable operations in Japan and the United States. Form 8-K reports furnish quarterly and annual results, supplemental earnings materials, investor presentations and Regulation FD disclosures tied to segment performance, premiums, investment income, dividends and share repurchases.
Proxy and annual-meeting filings cover board elections, executive compensation votes, auditor ratification, shareholder proposals and common-stock voting matters. Other material-event filings describe financing arrangements, including pre-capitalized trust securities and contingent senior-note funding, as well as cybersecurity incident disclosures, operational continuity, customer information risks, governance controls and public-company reporting obligations.
Aflac executive Charles D. Lake II, Chairman & Rep. Director, ALIJ, acquired 27,865 shares of Aflac common stock on February 10, 2026 through a grant under the Aflac Incorporated Long-Term Incentive Plan (as amended and restated February 14, 2017).
The shares were granted at a stated price of $0 per share, bringing his directly held beneficial ownership to 77,827 common shares. He also beneficially owns 1,320 common shares indirectly through a 401(k) plan.
Broden Max reported disposition transactions in a Form 4 filing for AFL. The filing lists transactions totaling 2,290 shares at a weighted average price of $113.20 per share. Following the reported transactions, holdings were 119,772 shares.
Aflac Inc. senior vice president and chief accounting officer Robin Littrell Blackmon reported a tax-withholding disposition of company stock. On February 9, 2026, 290 shares of Aflac common stock were surrendered at $113.20 per share to cover taxes, leaving 6,807 shares owned directly.
Aflac Senior Executive Vice President and Chief Financial Officer Max Broden reported a sale of company stock. On February 6, 2026, he sold 13,000 shares of Aflac common stock at a weighted average price of $117.665 per share in multiple transactions priced between $117.37 and $118.115.
After this sale, Broden directly beneficially owned 122,062 shares of Aflac common stock. In addition, there are 340 shares reported as indirectly owned through his spouse.
Aflac Inc filed a Form 13F reporting institutional holdings. The filing lists 3 information-table entries with a total value of $138,714,822 and notes 1 other included manager, Aflac Asset Management LLC. The report was signed by Robin Blackmon on 02-06-2026.
Aflac Incorporated has a Form 144 notice indicating a planned sale of 13,000 shares of its common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,529,646.00 and an approximate sale date of February 6, 2026.
The shares were acquired from the issuer as restricted stock vesting between 2018 and 2021 as compensation, in multiple small grants. The filing notes that 524,113,917 shares of common stock were outstanding, providing scale for the proposed sale.
Aflac Incorporated furnished information about its 2025 fourth quarter and full year 2025 financial results in connection with this current report. The company issued a press release, supplemental financial materials, and an investor presentation, and also provided a video discussion by its Senior Executive Vice President and Chief Financial Officer.
These materials, including the press release, financial supplement, transcript of the CFO’s comments, and presentation slides, are included as exhibits and referenced in full, giving investors multiple formats to review the company’s recent financial performance and commentary.
The Vanguard Group reported a major ownership position in Aflac Inc. common stock. Vanguard beneficially owns 57,141,127 Aflac shares, representing 10.9 % of the outstanding common stock as of the event date. Vanguard has no sole voting power over these shares, but has shared voting power over 3,018,037 shares. It has sole dispositive power over 52,252,431 shares and shared dispositive power over 4,888,696 shares.
The shares are held in the ordinary course of Vanguard’s investment management business, and the filing states they are not held for the purpose of changing or influencing control of Aflac. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends and sale proceeds, and no single other person’s interest exceeds 5 % of the class.
AFLAC Inc. Chairman, CEO and director Daniel P. Amos reported stock gifts involving company common shares. On 12/19/2025, he disposed of 161,175 shares of AFLAC common stock in a transaction coded as a gift at a reported price of $0, leaving 580,840 shares owned directly. On 12/22/2025, additional gift transactions were reported, including 240 shares acquired directly and 6 shares held indirectly through his spouse, both at a reported price of $0. After these transactions, he also reports indirect ownership of AFLAC shares through his spouse, a spouse IRA, a partnership and a trust for children.
AFL shareholder Steven K Beaver has filed a Rule 144 notice to sell 5,492 shares of the issuer’s common stock through broker LPL Financial, with an approximate sale date of 12/12/2025 on the NYSE. The notice lists an aggregate market value of 601,099.40 for this proposed sale and reports 524,113,917 shares of this class outstanding.
The securities to be sold come from 14,480 common shares acquired from the issuer as vested restricted stock on 02/11/2024, with cash shown as the form of payment dated 12/12/2025. The filing also reports that during the past three months Beaver sold 3,452 common shares on 12/05/2025 for gross proceeds of 377,165.88. By signing, the seller represents that he is not aware of any undisclosed material adverse information about the issuer.